digital therapeutics

News

Can Pear bud again? Ex-CEO McCann bids for assets

Digital therapeutics (DTx) company Pear Therapeutics may be heading for a new lease of life, if a plan by former chief executive Corey McCann pays off.

Digital

Is Pear’s demise a sign of things to come for digital therap...

As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of d

Digital

When will “digital health” just become health?

Despite the significant drop in funding in 2022, digital health is here to stay.

News

Pear Tx files for bankruptcy, will seek to sell assets

Boston-based Pear Therapeutics, one of the first digital therapeutics companies to secure FDA clearance and forge pharma partnerships, is bowing out.

News

Poll finds just one fifth of doctors have prescribed a DTx

A large, international survey of thousands of doctors has revealed that a majority are still not confident enough to prescribe

News

Future Health report: Expert opinion on digital therapeutics

Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert propo

Can Pear bud again? Ex-CEO McCann bids for assets

Is Pear’s demise a sign of things to come for digital therap...

When will “digital health” just become health?

Pear Tx files for bankruptcy, will seek to sell assets

Poll finds just one fifth of doctors have prescribed a DTx

Future Health report: Expert opinion on digital therapeutics

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

digital therapeutics

Editor's Picks